DUBLIN--(BUSINESS WIRE)--Nov. 7, 2012--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Jefferies 2012 Global Healthcare Conference
on Wednesday, November 14, 2012, at 9:20 a.m. GMT (4:20 a.m. EST) in
London. In addition, Alkermes’ corporate presentation will be webcast
live at the Credit Suisse 2012 Healthcare Conference on Wednesday,
November 14, 2012, at 3:00 p.m. MST (5:00 p.m. EST/10:00 p.m. GMT) from
Phoenix, Arizona. These presentations may be accessed under the
Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781-609-6823
Corporate
Communications
